Consolidated Balance Sheets Statement - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
CURRENT ASSETS:
Cash and cash equivalents	$ 22,580	$ 23,350
Accounts receivable, net of allowance for doubtful accounts of $3,731 and $3,397 at 2015 and 2014, respectively	155,112	197,163
Inventories	47,585	43,371
Prepaid expenses	14,663	14,246
Income taxes receivable	13,836	10,980
Other current assets	12,872	12,710
TOTAL CURRENT ASSETS	266,648	301,820
PROPERTY, PLANT AND EQUIPMENT, net	148,452	149,014
INTANGIBLES, net	12,667	10,642
GOODWILL	178,718	164,464
DEFERRED TAX ASSETS, net	5,857	3,876
OTHER ASSETS	46,643	45,837
TOTAL ASSETS	658,985	675,653
CURRENT LIABILITIES:
Accounts payable	42,323	47,084
Accrued payroll and related costs	38,412	34,617
Taxes other than payroll and income	9,187	11,199
Unearned revenue	14,757	11,009
Income taxes payable	8,320	8,333
Other current liabilities	23,881	19,624
TOTAL CURRENT LIABILITIES	136,880	131,866
LONG-TERM DEBT	421,508	356,000
DEFERRED COMPENSATION	43,971	42,705
DEFERRED TAX LIABILITIES, net	6,068	7,210
OTHER LONG-TERM LIABILITIES	$ 43,298	$ 43,879
COMMITMENTS AND CONTINGENCIES (Note 6)
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	$ 0	$ 0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 45,600,002 issued and 42,656,736 outstanding at 2015 and 45,600,002 issued and 43,636,984 outstanding at 2014	1,174	1,174
Additional paid-in capital	0	0
Retained earnings	432,812	415,906
Accumulated other comprehensive income (loss)	(11,232)	(11,894)
Treasury shares (at cost), 2,943,266 at 2015 and 1,963,018 at 2014	(421,633)	(317,613)
Total Core Laboratories N.V. shareholders' equity	1,121	87,573
Non-controlling interest	6,139	6,420
TOTAL EQUITY	7,260	93,993
TOTAL LIABILITIES AND EQUITY	$ 658,985	$ 675,653